Cargando…

Cognitive impairment and “invisible symptoms” are not associated with CCSVI in MS

BACKGROUND: We investigated the association between chronic cerebrospinal venous insufficiency (CCSVI) and cognitive impairment (CI) in multiple sclerosis (MS). Moreover, we evaluated the association between CCSVI and other frequent self-reported MS symptoms. METHODS: We looked at the presence of CI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leone, Carmela, D’Amico, Emanuele, Cilia, Sabina, Nicoletti, Alessandra, Di Pino, Luigi, Patti, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734156/ https://www.ncbi.nlm.nih.gov/pubmed/23889853 http://dx.doi.org/10.1186/1471-2377-13-97

Ejemplares similares

Multiple Sclerosis and CCSVI: A Population-Based Case Control Study
por: Patti, Francesco, et al.
Publicado: (2012)

The perfect crime? CCSVI not leaving a trace in MS
por: Mayer, Christoph A, et al.
Publicado: (2011)

“Media, politics and science policy: MS and evidence from the CCSVI Trenches”
por: Pullman, Daryl, et al.
Publicado: (2013)

Offspring Number Does Not Influence Reaching the Disability’s Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up
por: Van den Berg, Petronella J., et al.
Publicado: (2013)

Resilience, trust, and civic engagement in the post-CCSVI era
por: Benjaminy, Shelly, et al.
Publicado: (2018)

Self-Reported Diet and Health Outcomes of Participants of the CCSVI-Tracking Survey Study
por: Grace-Farfaglia, Patricia
Publicado: (2021)

Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers
por: Dolic, Kresimir, et al.
Publicado: (2011)

Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
por: Comi, Giancarlo, et al.
Publicado: (2013)

Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: Results of the PREMiSe pilot study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists – a qualitative study
por: Driedger, S. Michelle, et al.
Publicado: (2017)

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study
por: Zanghì, Aurora, et al.
Publicado: (2022)

Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
por: Zanghì, Aurora, et al.
Publicado: (2021)

The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2019)

Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Negative prognostic impact of MRI spinal lesions in the early stages of relapsing–remitting multiple sclerosis
por: D’Amico, E, et al.
Publicado: (2016)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Toxoplasma gondii and multiple sclerosis: a population-based case–control study
por: Nicoletti, Alessandra, et al.
Publicado: (2020)

Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI
por: Messina, Silvia, et al.
Publicado: (2014)

Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown
por: Baschi, Roberta, et al.
Publicado: (2020)

$\tau \to \ell +$ invisible through invisible-savvy collider variables
por: Guadagnoli, Diego, et al.
Publicado: (2021)

Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report
por: Patti, Francesco, et al.
Publicado: (2015)

“Invisible” visual impairments. A qualitative study of stroke survivors` experience of vision symptoms, health services and impact of visual impairments
por: Falkenberg, Helle K., et al.
Publicado: (2020)

Whole Grape Pomace Flour as Nutritive Ingredient for Enriched Durum Wheat Pasta with Bioactive Potential
por: Gerardi, Carmela, et al.
Publicado: (2023)

Absolute and relative quantitation of amylase/trypsin-inhibitors by LC-MS/MS from wheat lines obtained by CRISPR-Cas9 and RNAi
por: Geisslitz, Sabrina, et al.
Publicado: (2022)

White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s disease
por: Misquitta, Karen, et al.
Publicado: (2020)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

The Mirror Neurons Network in Aging, Mild Cognitive Impairment, and Alzheimer Disease: A functional MRI Study
por: Farina, Elisabetta, et al.
Publicado: (2017)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Motor, cognitive, and combined rehabilitation approaches on MS patients’ cognitive impairment
por: Argento, Ornella, et al.
Publicado: (2022)

Invisible /
por: Auster, Paul, 1947-
Publicado: (2009)

Invisible
por: Herrera, Jorge Luis
Publicado: (2019)

Visualizing the Invisible: Invisible Waste in Diagnostic Imaging
por: Hofmann, Bjørn, et al.
Publicado: (2021)

New energy with ZnS: novel applications for a standard transparent compound
por: D’Amico, Pino, et al.
Publicado: (2017)

Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
por: Zanghì, Aurora, et al.
Publicado: (2022)

Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis
por: Ziccardi, Stefano, et al.
Publicado: (2022)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Cross-wavelength invisibility integrated with various invisibility tactics
por: Xu, Su, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_673cab0c6atlcnnj5utht71fo7